Controlling for Severity of Illness in Outcome Studies Involving Infectious Diseases: Impact of Measurement at Different Time Points

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Infection Control & Hospital Epidemiology

• Publication date

  2008-09-25

• Fields of study

  Medicine

• Identifiers
  DOI 10.1086/591453PMID 18817505PMCID PMC2716043
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Controlling for Severity of Illness in Assessment of the Association Between Antimicrobial-Resistant Infection and Mortality: Impact of Calculation of Acute Physiology and Chronic Health Evaluation (APACHE) II Scores at Different Time Points

  2007cited by this paper
• A systematic review of the methods used to assess the association between appropriate antibiotic therapy and mortality in bacteremic patients.

  2007cited by this paper
• Multidrug-resistant Acinetobacter Infection Mortality Rate and Length of Hospitalization

  2007cited by this paper
• Comparison of severity of illness scoring systems for patients with nosocomial bloodstream infection due to Pseudomonas aeruginosa

  2006cited by this paper
• Impact of Empiric Antibiotic Therapy on Outcomes in Patients with Pseudomonas aeruginosa Bacteremia

  2006cited by this paper
• Nosocomial bloodstream infections caused by Klebsiella pneumoniae: impact of extended-spectrum β-lactamase (ESBL) production on clinical outcome in a hospital with high ESBL prevalence

  2006cited by this paper
• Utility of the Chronic Disease Score and Charlson Comorbidity Index as comorbidity measures for use in epidemiologic studies of antibiotic-resistant organisms.

  2005cited by this paper
• Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study.

  2004cited by this paper
• Bloodstream Infections Due to Extended-Spectrum β-Lactamase-Producing Escherichia coli and Klebsiella pneumoniae: Risk Factors for Mortality and Treatment Outcome, with Special Emphasis on Antimicrobial Therapy

  2004cited by this paper
• Pseudomonas aeruginosa bacteremia: risk factors for mortality and influence of delayed receipt of effective antimicrobial therapy on clinical outcome.

  2003cited by this paper
• Inappropriate initial antimicrobial therapy and its effect on survival in a clinical trial of immunomodulating therapy for severe sepsis.

  2003cited by this paper
• Performance standards for antimicrobial susceptibility testing

  2001cited by this paper
• Excess shock and mortality in Staphylococcus aureus related to methicillin resistance.

  2000cited by this paper
• Epidemiology of Klebsiella bacteraemia: a case control study using Escherichia coli bacteraemia as control.

  1998cited by this paper
• Epidemiology and outcome of Pseudomonas aeruginosa bacteremia, with special emphasis on the influence of antibiotic treatment. Analysis of 189 episodes.

  1996cited by this paper
• Bacteraemia due to Escherichia coli in a Danish university hospital, 1986-1990.

  1995cited by this paper
• Klebsiella bacteremia: a review of 196 episodes during a decade (1980-1989).

  1991cited by this paper
• The APACHE III prognostic system. Risk prediction of hospital mortality for critically ill hospitalized adults.

  1991cited by this paper
• Analysis of 1,186 episodes of gram-negative bacteremia in non-university hospitals: the effects of antimicrobial therapy.

  1983cited by this paper

• Nomenclature, definitions, and methodological approaches to estimate the association between antimicrobial treatment and clinical outcomes of drug-resistant bloodstream infections.

  2025cites this paper
• Attributable Patient Cost of Antimicrobial Resistance: A Prospective Parallel Cohort Study in Two Public Teaching Hospitals in Ghana

  2023cites this paper
• Economic Burden of Urinary Tract Infections From Antibiotic-Resistant Escherichia coli Among Hospitalized Adult Patients in Lebanon: A Prospective Cohort Study.

  2021cites this paper
• Methodological quality of studies evaluating the burden of drug-resistant infections in humans due to the WHO Global Antimicrobial Resistance Surveillance System target bacteria

  2021cites this paper
• Impact of early antimicrobial stewardship intervention in patients with positive blood cultures: results from a randomized comparative study: Impact of stewardship on BSI outcomes.

  2021cites this paper
• Models for Assessing Severity of Illness in Patients with Bloodstream Infection: a Narrative Review

  2021cites this paper
• The healthcare costs of antimicrobial resistance in Lebanon: a multi-centre prospective cohort study from the payer perspective

  2021cites this paper
• Economic Burden of Urinary Tract Infections From Antibiotic-Resistant Escherichia coli Among Hospitalized Adult Patients in Lebanon: A Prospective Cohort Study.

  2021cites this paper
• Effect of oral vancomycin dose on outcomes in patients with Clostridioides difficile infection.

  2021cites this paper
• Exploring the Relationship between FEV1 Loss and Recovery and Aminoglycoside Pharmacokinetics in Adult Patients with Cystic Fibrosis: Implications for Clinical Dosing Strategies

  2020cites this paper
• A review on β-lactam antibiotic drug resistance

  2020cites this paper
• Appropriate empirical antibiotic therapy and mortality: Conflicting data explained by residual confounding

  2019cites this paper
• Using the best available data to estimate the cost of antimicrobial resistance: a systematic review

  2019cites this paper
• Survival in Patients with Candida glabrata Bloodstream Infection Is Associated with Fluconazole Dose

  2018cites this paper
• Development and Validation of a Clostridium difficile Infection Risk Prediction Model Author ( s ) :

  2018cites this paper
• Resistance Trends and Treatment Options in Gram-Negative Ventilator-Associated Pneumonia

  2018cites this paper
• Implementation of a cefazolin-based stewardship pathway for methicillin-susceptible Staphylococcus aureus bloodstream infections paired with infectious diseases consultation.

  2017cites this paper
• Prolonged Infusion Piperacillin-Tazobactam Decreases Mortality and Improves Outcomes in Severely Ill Patients: Results of a Systematic Review and Meta-Analysis*

  2017cites this paper
• Tree-Based Models for Predicting Mortality in Gram-Negative Bacteremia: Avoid Putting the CART before the Horse

  2015cites this paper
• Appropriate initial antibiotic therapy in hospitalized patients with gram-negative infections: systematic review and meta-analysis

  2015cites this paper
• Defining Clinical Exposures of Cefepime for Gram-Negative Bloodstream Infections That Are Associated with Improved Survival

  2015cites this paper
• Evaluation of clinical outcomes in patients with Gram-negative bloodstream infections according to cefepime MIC.

  2015cites this paper
• Treatment Outcomes with Cefazolin versus Oxacillin for Deep-Seated Methicillin-Susceptible Staphylococcus aureus Bloodstream Infections

  2015cites this paper
• Clinical Laboratory–Based Assay Methodologies May Underestimate and Increase Variability of Vancomycin Protein Binding in Hospitalized Patients

  2014cites this paper
• Economic burden of antibiotic resistance: how much do we really know?

  2014cites this paper
• Quantifying the clinical virulence of Klebsiella pneumoniae producing carbapenemase Klebsiella pneumoniae with a Galleria mellonella model and a pilot study to translate to patient outcomes

  2014cites this paper
• Fluconazole versus an echinocandin for Candida glabrata fungaemia: a retrospective cohort study.

  2013cites this paper
• Commentary: Back to the future with Sir Bradford Hill: statistical analysis with hospital-acquired infections.

  2013cites this paper
• Outcome of carbapenem resistant Klebsiella pneumoniae bloodstream infections.

  2012cites this paper
• Incidence and predictors of acute kidney injury associated with intravenous polymyxin B therapy.

  2012cites this paper
• Catheter Related Bloodstream Infection (CR-BSI) in ICU Patients: Making the Decision to Remove or Not to Remove the Central Venous Catheter

  2012cites this paper
• The Utility of Acute Physiology and Chronic Health Evaluation II Scores for Prediction of Mortality among Intensive Care Unit (ICU) and Non-ICU Patients with Methicillin-Resistant Staphylococcus aureus Bacteremia

  2012cites this paper
• Blood culture status and mortality among patients with suspected community-acquired bacteremia: a population-based cohort study

  2011cites this paper
• Clinical epidemiology of carbapenem-intermediate or -resistant Enterobacteriaceae.

  2011cites this paper
• Development and Validation of a Clostridium difficile Infection Risk Prediction Model

  2011cites this paper
• Predictors of agr Dysfunction in Methicillin-Resistant Staphylococcus aureus (MRSA) Isolates among Patients with MRSA Bloodstream Infections

  2011cites this paper
• Refining Vancomycin Protein Binding Estimates: Identification of Clinical Factors That Influence Protein Binding

  2011cites this paper
• Systematic Review and Meta-Analysis of the Efficacy of Appropriate Empiric Antibiotic Therapy for Sepsis

  2010cites this paper
• Carbapenem-resistant Klebsiella pneumoniae bacteremia: factors correlated with clinical and microbiologic outcomes.

  2010cites this paper
• Intrathecal colistin for drug-resistant Acinetobacter baumannii central nervous system infection: a case series and systematic review.

  2010cites this paper
• Diagnosis and prognosis of patients with community- acquired bacteremia

  2009cites this paper
• Digital Commons@Becker

  year unknowncites this paper